Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksINS.L Share News (INS)

  • There is currently no data for INS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

24 Mar 2015 06:23

Earnings, Trading Statements Calendar - Week Ahead

Read more
23 Mar 2015 16:08

Earnings, Trading Statements Calendar - Week Ahead

Read more
13 Feb 2015 08:57

Instem Pays GBP300,000 Earn-Out For Perceptive Instruments

Read more
12 Jan 2015 14:47

Instem on track to meet target after FDA boosts outlook

Strong order intake has seen IT supplier Instem begin 2015 with its largest ever opening sales backlog. The firm, which supplies IT applications to drug developers, said it expects to meet full year's expectations for 2014 after a "very encouraging" final quarter. House broker Singer N+1 said this

Read more
12 Jan 2015 09:06

Instem To Meet Market Expectations For Full Year After Strong Finish

Read more
10 Nov 2014 09:35

Instem Gets New Contracts, But Still Awaiting Its High-Value Deals

Read more
24 Sep 2014 12:03

UK MIDDAY BRIEFING: RBS Forced To Cut Citizens IPO Price

Read more
24 Sep 2014 11:14

UK WINNERS & LOSERS: Rightmove, Zoopla Knocked By Citigroup Ratings

Read more
24 Sep 2014 07:58

Instem Warns For Full-Year Results On Contract Uncertainty

Read more
1 Aug 2014 09:07

Instem Makes Second Earn Out Payment For Logos

Read more
16 Jul 2014 08:46

Instem Wins Two Asia-Pacific Contracts

Read more
1 May 2014 11:02

Instem Wins Contract With US's WIL Research Laboratories

LONDON (Alliance News) - Healthcare IT company Instem PLC said Thursday it had won a contract with the US's WIL Research Laboratories LLC to replace its existing study management systems at its sites. Under the contract, Ashland, Ohio-based WIL Research has chosen Instem's Provantis softwar

Read more
26 Mar 2014 15:50

Buoyant Instem sees improvement in end markets

Shares in Instem, a provider of IT systems to preclinical biotech companies, rose on encouraging results for 2013 and news that its end-markets were returning to health. The AIM-listed company drove adjusted earnings up 10.3% to 8.6p per share on a 8% increase in adjusted operating profit to £8.2m

Read more
26 Mar 2014 15:04

UPDATE: Instem Confident For 2014 As Pretax Profit Hit By Acquisition Costs

LONDON (Alliance News) - Instem PLC Wednesday expressed confidence for 2014, benefiting from full-year contributions from recent acquisitions, as it saw pretax profit decline in 2013. The company provides information technology products to the early development healthcare market. The

Read more
26 Mar 2014 09:31

Instem Confident For 2014 As Pretax Profit Hit By Acquisition Costs

LONDON (Alliance News) - Instem PLC Wednesday expressed confidence for 2014, benefiting from full-year contributions from recent acquisitions, as it saw pretax profit decline in 2013. The company provides information technology products to the early development healthcare market. The

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.